<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Indian J Ophthalmol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Indian J Ophthalmol</journal-id>
      <journal-id journal-id-type="publisher-id">IJO</journal-id>
      <journal-title-group>
        <journal-title>Indian Journal of Ophthalmology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0301-4738</issn>
      <issn pub-type="epub">1998-3689</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26044487</article-id>
      <article-id pub-id-type="pmc">4463574</article-id>
      <article-id pub-id-type="publisher-id">IJO-63-362</article-id>
      <article-id pub-id-type="doi">10.4103/0301-4738.158109</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Full thickness macular hole following intravitreal ranibizumab injection for diabetic macular edema; a rare complication or coincidence?</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Arifoglu</surname>
            <given-names>Hasan Basri</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Karatepe Hashas</surname>
            <given-names>Arzu Seyhan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ersekerci</surname>
            <given-names>T&#xFC;lay</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Atas</surname>
            <given-names>Mustafa</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Kayseri Research and Education Hospital, Kayseri, Turkey</aff>
      <aff id="aff2"><label>1</label>Finike State Hospital, Antalya, Turkey</aff>
      <author-notes>
        <corresp id="cor1"><bold>Correspondence to:</bold> Dr. Arzu Seyhan Karatepe Hashas, Kayseri Research and Education Hospital, Kayseri, Turkey. E-mail: <email xlink:href="arzuskaratepe@hotmail.com">arzuskaratepe@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2015</year>
      </pub-date>
      <volume>63</volume>
      <issue>4</issue>
      <fpage>362</fpage>
      <lpage>363</lpage>
      <permissions>
        <copyright-statement>Copyright: &#xA9; Indian Journal of Ophthalmology</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Dear Sir,</p>
    <p>Anti-vascular endothelial growth factors (VEGFs) improved vision and macular edema in patients with diabetic macula edema and reduced the risk of further visual loss. We report a 67-year-old woman with type 2 diabetes mellitus who had panretinal photocoagulation for proliferative diabetic retinopathy presented at our department for decreased vision in her right eye (RE). On examination, best corrected visual acuity (BCVA) was 20/400 in the RE. Anterior segment examination was unremarkable and funduscopy of the RE revealed cystoid macular edema (CME). There was no posterior vitreous detachment (PVD) or clinically detectable vitreomacular traction (VMT). Fluorescein angiography of the RE showed late hyperfluorescence in the macular area due to leakage from microaneurysms and areas of increased vascular permeability [<xref ref-type="fig" rid="F1">Fig. 1</xref>]. Optical coherence tomography (OCT) (The Heidelberg Spectralis OCT, Heidelberg Engineering, Inc., Heidelberg, Germany) confirmed the presence of cystoid DME without VMT [<xref ref-type="fig" rid="F2">Fig. 2</xref>]. Central foveal thickness was 830 &#x3BC;m. An informed consent form was taken and intravitreal 0.5 mg ranibizumab injection (Lucentis; Genentech, South San Francisco, CA, USA and Novartis, Basel, Switzerland) was administered without complication.</p>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Fluorescein angiography of the eye showing late hyperfluorescence in the macular area</p>
      </caption>
      <graphic xlink:href="IJO-63-362-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Patient optical coherence tomography scan depicting cystoid macular edema without vitreoretinal traction</p>
      </caption>
      <graphic xlink:href="IJO-63-362-g002"/>
    </fig>
    <p>One-month after the injection of anti-VEGF, patient complained of newly developed metamorphopsia. BCVA deteriorated to 6/200 and slip-lamp biomicroscopy revealed a full thickness macular hole (FTMH) with no PVD or VMT. OCT confirmed the presence of a FTHM and no evidence of any areas of partial vitreous separation associated with vitreoretinal adhesions or areas of vitreous traction in any OCT scan [<xref ref-type="fig" rid="F3">Fig. 3</xref>]. Patient underwent pars plana vitrectomy, internal limiting membrane peeling and fluid gas exchange (SF6). One-month after the surgery there was no FTMH or CME and BCVA improved to 20/200.</p>
    <fig id="F3" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Patient optical coherence tomography scan depicting cystoid macular edema and full-thickness macular hole 1-month after intravitreal injection</p>
      </caption>
      <graphic xlink:href="IJO-63-362-g003"/>
    </fig>
    <p>Anterior-posterior traction by the vitreous on the macula causes idiopathic FTMH. Pathogenetic mechanism of FTMH associated with macular edema is unclear. A few studies were presented macular hole formation after intravitreal injections for CME.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref>]</p>
    <p>Georgalas <italic>et al</italic>. postulated that retinal changes due to the massive CME, the absence of PVD in combination with the vitreous traction induced either by the mechanical globe deformation and vitreous synaeresis or by a possible vitreous incarceration at the injection site, could lead to the development of FTMH in central retinal vein occlusion.[<xref rid="ref1" ref-type="bibr">1</xref>]</p>
    <p>Lecleire-Collet <italic>et al</italic>. have reported a patient with diabetic maculopathy who developed a FTMH after repeated intravitreal triamcinolone injections.[<xref rid="ref2" ref-type="bibr">2</xref>] The authors postulated that repeated intravitreal injections might had an indirect role in the development of FTMH formation by favoring the rupture of distended M&#xFC;ller cells and intraretinal pseudocysts. During breakdown of the blood-retina barrier, M&#xFC;ller cells become swollen and are eventually lysed. This results in extracellular fluid accumulation in the outer plexiform and inner nuclear layers. Consequently, CME can be caused directly, due to endothelial cell damage, as it occurs in the context of diabetes mellitus may lead to macular hole development.[<xref rid="ref4" ref-type="bibr">4</xref>] Hussain <italic>et al</italic>. reported a FTMH after foveal pseudocyst formation in vitrectomized eye and they hypothesised that Muller cell insult was a probable hypothesis of FTMH.[<xref rid="ref5" ref-type="bibr">5</xref>]</p>
    <p>In conclusion, although development of macular hole is a rare adverse effect of the anti-VEGF injection, this possibility must be kept in mind. Further investigations are required to confirm our results.</p>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Georgalas</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Rouvas</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kotsolis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Karagiannis</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ladas</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Full thickness macular hole formation in a patient with cystoid macular edema caused by CRVO treated with intravitreal bevacizicumab</article-title>
          <source>Ophthalmic Surg Lasers Imaging</source>
          <year>2010</year>
          <month>3</month>
          <day>9</day>
          <fpage>1</fpage>
          <lpage>4</lpage>
          <comment>Epub ahead of print</comment>
          <pub-id pub-id-type="pmid">20337340</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lecleire-Collet</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Offret</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Gaucher</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Audren</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Haouchine</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Massin</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Full-thickness macular hole in a patient with diabetic cystoid macular oedema treated by intravitreal triamcinolone injections</article-title>
          <source>Acta Ophthalmol Scand</source>
          <year>2007</year>
          <volume>85</volume>
          <fpage>795</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">17459030</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Erdurman</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Pellumbi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Durukan</surname>
              <given-names>AH</given-names>
            </name>
          </person-group>
          <article-title>Lamellar macular hole formation in a patient with diabetic CME treated by intravitreal bevacizumab injections</article-title>
          <source>Ophthalmic Surg Lasers Imaging</source>
          <year>2012</year>
          <volume>43</volume>
          <fpage>e87</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">22938703</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moschos</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Gatzioufas</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Rotsos</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Symeonidis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Seitz</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Macular hole formation in a patient with Irvine-Gass syndrome: Coincidence or rare complication?</article-title>
          <source>Clin Ophthalmol</source>
          <year>2013</year>
          <volume>7</volume>
          <fpage>1437</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">23885166</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hussain</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hussain</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Natarajan</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Optical coherence tomographic evaluation of foveal pseudocyst in the formation of macular hole</article-title>
          <source>Indian J Ophthalmol</source>
          <year>2003</year>
          <volume>51</volume>
          <fpage>353</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">14750627</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
